In patients with head and neck cancer, high amounts of activated caspase-3 were correlated with high rates of tumour recurrence, and in patients with breast cancer, high caspase-3 levels were correlated with shorter survival time [39]. The gene discussed is CASP3; the disease is neoplasm.